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Objectives: we assessed the effects of cryopreservation on smooth-muscle cell injury in human vein.
Materials and methods: long saphenous vein was collected during surgery and cryopreserved. Smooth-muscle cell
damage was assessed after thawing by in situ detection of fragmented DNA. The presence of cryoprotectant (10%
dimethyl sulphoxide, DMSO), cooling and warming rates, and the rate of cryoprotectant removal after thawing were
examined.
Results: control veins exhibited damage in 8.5% (95% confidence interval (CI) 4.7 to 13.4%, n=13) of smooth-muscle
cells compared with 27.7% (95% CI 23.2 to 32.4%, n=115) in vein frozen in 10% DMSO (p=0.001). In the presence
of DMSO, damage to smooth-muscle cells was independent of the rates of cooling (p=0.72) and warming (p=0.45).
The rate of dilution to remove the cryoprotectant after thawing also had no effect on cell damage (p=0.64). In the absence
of cryoprotectant, cell damage was doubled to approximately 50% by slow rather than rapid warming (p=0.01).
Conclusion: cooling rate, and the presence of a cryoprotectant, has little effect on smooth-muscle damage, provided that
the tissue is warmed rapidly. Slow warming, in the absence of DMSO, causes substantial damage. These results suggest
that simplified methods of vein cryopreservation are feasible.
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Introduction the degree of injury sustained by tissue during cryo-
preservation. At high cooling rates, damage is a result
Venous allografts exhibit comparable patency rates to of ice crystallisation inside cells; conversely, at low
synthetic alternatives and are more resistant to graft cooling rates, the formation of extracellular ice exposes
sepsis.1–4 These properties are an advantage in haemo- cells to highly concentrated electrolyte solutions and
dialysis access and peripheral bypass surgery in the brings about extreme cellular dehydration.5,6 The op-
presence of sepsis. Cryopreservation of vein allografts timum cooling rate is a compromise that aims to min-
would allow the long-term storage of venous tissue imise the effects of these two competing mechanisms
until it is required for surgical procedures. At tem- of freezing injury.
peratures below -140 °C, all biochemical reactions The cryoprotectant dimethyl sulphoxide (DMSO) is
have ceased, allowing virtually indefinite storage of often used in the cryopreservation of mammalian cells
living tissue. The development of straightforward re- and tissues, including vascular tissue. Cryoprotectants
trieval and cryopreservation protocols for veins would act by reducing the rise in electrolyte concentration
expand the availability and potential usefulness of during freezing and thus protect cells against slow-
vascular allografts. Such protocols would need to min- cooling injury. Cryoprotectants, however, can them-
imise cellular injury and maintain the structural in- selves also damage cells through chemical toxicity or
tegrity of the graft. detrimental osmotic effects. Dimethyl sulphoxide is a
Freezing and thawing can cause substantial injury so-called permeating cryoprotectant that readily
to cells and tissues. The rates of cooling to and warming crosses cell membranes, and its abrupt withdrawal
from the storage temperature, the use of cryo- from tissues after thawing can cause osmotic damage
protectants (compounds that protect cells against to cells. Protocols for the withdrawal of cryoprotectant
freezing injury), and manner of cryoprotectant ad- from a tissue that are designed to reduce cellular
dition to and removal from the tissue, all influence osmotic stress involve a gradual reduction in cryo-
protectant concentration, usually in a series of steps.
* Please address all correspondence to: D. C. Mitchell, Department The efficacy of this technique has been demonstratedof Surgery, Southmead Hospital, Westbury-on-Trym, Bristol BS10
5NB, U.K. with isolated cells, such as blood platelets,7 where the
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cell volume changes can be calculated during changes aluminium foil pouches and cooled either slowly or
rapidly. Slow cooling was at a controlled rate of 1 °C/in permeating cryoprotectant concentration.
Many of the currently used cryopreservation tech- min to -100 °C (Planar Kryo 10–16 programmable
cooling machine) followed by transfer to the gas phaseniques were originally developed from experiments
performed in cell suspensions and tissue cultures. of a liquid nitrogen refrigerator (<-140 °C). Rapid
cooling was achieved simply by placing the samplesCells within a tissue matrix, however, are subject to
additional factors that may exacerbate freezing injury, directly in the gas phase of the liquid nitrogen re-
frigerator. This gave a rate of cooling of 6 °C/minsuch as the presence of cell–cell and cell–matrix inter-
actions, large temperature and solute gradients within between-15 and-65 °C. Samples were thawed either
by immersing individual nylon sachets directly in athe tissue, restricted exchange of water across cell
membranes and poor penetration of cryoprotectant. water bath at 37 °C (rapid warming, 86 °C/min be-
tween -65 and -15 °C), or by leaving the nylonOur experiments were designed to investigate the
effects of freezing on smooth-muscle cell damage in sachets in air at 24 °C (slow warming, 5 °C/min be-
tween -65 and -15 °C).human saphenous vein. We aimed to produce a sim-
plified technique for the cryopreservation and sub-
sequent use of venous allografts whilst minimising In situ end labelling (ISEL) of fragmented DNA
smooth-muscle cell injury.
We have used this technique previously for de-
termining smooth-muscle cell damage in veins.10 Frag-
Materials and Methods mented DNA was detected using ISEL to determine
the number of apoptotic cells. All reagents used were
Vein collection and processing obtained from Sigma apart from where stated dif-
ferently. Briefly, deparaffinised and rehydrated 5-lm
Human long saphenous veins were collected from 13 transverse sections were incubated at room tem-
patients undergoing varicose-vein-stripping pro- perature with 5 lg/ml proteinase K for 15 min. After
cedures. Veins were not inverted during stripping. The washing in 1· Tris-EDTA buffer (TE, 10 mM Tris·Cl,
vein samples were collected into modified Hank’s 1 mM EDTA), the slides were incubated in reaction
balanced salt solution at room temperature and pro- buffer containing 0.01 mM dATP, dCTP, dGTP and
cessed within 4 h. Each vein was opened lon- biotin-16-dUTP (Boehringer Mannheim), 8 U/ml DNA
gitudinally, washed in Hartmann’s solution and polymerase I (Klenow) large fragment (Promega),
sectioned into approximately 1-cm2 sections prior to 50 mM Tris·Cl pH 7.2, 10 mM MgSO4, 0.1 mM DTT, for
use in experiments. 15 min at room temperature. The slides were rinsed
in 1·TE and then endogenous peroxidase activity
inhibited by 2% hydrogen peroxide. After rinsing in
1·TE, the slides were incubated in ExtravidinÔ horse-Cryoprotectant addition and removal
radish peroxidase diluted 1:200 in 10% fetal bovine
serum (FBS) in phosphate-buffered saline (PBS) forThe cryoprotectant was added in two steps. Vein
30 min at room temperature. Sections were developedsamples were first placed in 5% DMSO in modified
with 0.5% 3,3-diaminobenzidine, 0.03% (v/v) hy-Hank’s solution at 4 °C for 10 min, and then in 10%
drogen peroxide in PBS after washing twice in PBS andDMSO for a further 10 min prior to freezing. Removal
were then counterstained with haematoxylin. Controlof the DMSO after thawing was by either slow or
slides, where either the DNA polymerase I (Klenow)rapid dilution in Hartmann’s solution at 20 °C. Slow
large fragment was omitted or the ExtravidinÔ horse-dilution was achieved by a 4-step protocol, each step
radish peroxidase was substituted with 10% FBS inlasting 3 min, in which the DMSO concentration was
PBS, were always included. The number of unlabelledreduced sequentially to 7.5%, 5%, 2.5%, and 0%. Rapid
and total number of smooth-muscle cells were counteddilution was by abrupt transfer of vein samples directly
in three independent areas of 0.25 mm2. Results wereinto Hartmann’s solution.
expressed as percent damaged cells.
Organ cultureFreezing and thawing
Vein samples were placed in culture medium in 12-Vein samples were frozen in 20 ml of solution in nylon
sachets. Batches of five nylon sachets were sealed in well plates and incubated for 24 h at 37 °C in an
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atmosphere of 5% CO2 in air. The culture medium
comprised RPMI 1640 buffered with 2 g/l NaHCO3,
supplemented with 2 mM L-glutamine, 8 lg/ml gen-
tamicin, 100 lg/ml streptomycin, 100 IU/ml penicillin
and 30% (v/v) fetal bovine serum.
Experimental protocol
Twelve groups, each comprising 13 samples of sa-
phenous vein, were cryopreserved to determine the
influence of the following four variables: presence or
absence of DMSO, rate of removal of DMSO, rate of
cooling, and rate of warming. Following a 6-month Fig. 1. Percentage of damaged smooth-muscle cells (back-trans-
period of storage at <-140 °C, tissue was thawed, and formed mean with 95% CI) in vein samples frozen in 10% DMSO
to show the effects of cooling rate, warming rate and rate ofthe cryoprotectant (if present) removed by dilution.
dilution of DMSO (SC=slow cooling; RC=rapid cooling; SW=The vein samples were placed in organ culture for slow warming; RW=rapid warming).
24 h to allow time for expression of cellular injury and
then assessed histologically for evidence of smooth- Vein frozen in 10% DMSO
muscle cell injury using the ISEL technique. Results
were expressed as the percentage of smooth-muscle Fig. 1 shows that when vein samples were frozen in
cells showing evidence of injury. Samples of untreated 10% DMSO, cell damage was similar regardless of the
veins that had not undergone cryopreservation were rates of cooling (p=0.72) and warming (p=0.45). The
processed in an identical manner and used as controls. rate of dilution of the cryoprotectant also had little
influence on cell damage after freezing and thawing
(p=0.64).
Statistical analysis
Because many of the results were below 20%, the data Effect of cryoprotectant
were subjected to arcsine transformation (h=arcsin
àp, where p is a proportion) before further analysis. There was a significant effect of warming rate, but
Back-transformed means are quoted with 95% con- this was strongly dependent on whether DMSO was
fidence intervals (95% CI). Comparisons between the present or absent (interaction term, p=0.03): when
different cryopreserved groups were made by three- warming was rapid, cell damage was similar under
way analyses of variance. The level of damage in the all conditions; but, in tissue frozen without cryo-
pooled frozen groups (excluding veins frozen without protectant, slow warming resulted in a substantial
cryoprotectant) was compared with the controls by t- increase in cell damage, an effect not observed in the
test. The level of significance was set at 5%. presence of DMSO (Fig. 2). Cooling rate had little
overall effect on cell damage (p=0.36). Provided, there-
fore, that frozen tissue was warmed rapidly, neither
cooling rate nor the presence of DMSO had any great
Results influence on smooth-muscle cell damage after thawing.
Control veins
In the unfrozen control veins, 8.5% (95% CI 4.7 to Discussion
13.4%, n=13) of smooth-muscle cells were damaged.
This was significantly less (p=0.001) than the extent The main arguments against the use of cryopreserved
vascular grafts are lack of availability, owing to theof damage in the groups that had undergone cryo-
preservation with 10% DMSO, which showed an over- difficulty of obtaining and preserving such tissue, and
aneurysmal degeneration following implantation.1,3all mean of 27.7% (95% CI 23.3 to 32.4%, n=115)
damaged cells. Cryopreserved grafts, however, have demonstrated
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remove the DMSO, rather than a sequential dilution
protocol. Our results suggest that cryopreservation of
venous tissue may be achieved without the need for
expensive programmable controlled-rate cooling
equipment. The presence of DMSO is desirable, since
slow warming may be necessary to avoid cracking in
whole-vein allografts. Complex dilution of cryo-
protectant from grafts, however, would appear to be
unnecessary. These results are encouraging and in-
dicate that cryopreservation of venous tissue, for ex-
ample for haemodialysis access, may be achieved using
straightforward methods. Before such a technique
could be applied, however, the results need to be
confirmed in venous tissue using a measure of smooth-Fig. 2. Percentage of damaged smooth-muscle cells (back-trans-
formed mean with 95% CI) in vein samples after freezing and muscle function. The process then also needs to be
thawing to show the effects of cooling rate, warming rate and the scaled up for use in whole-vein allografts.presence or absence of 10% DMSO (SC=slow cooling; RC=rapid
cooling; SW=slow warming; RW=rapid warming).
Summarysepsis resistance compared with synthetic alternatives,
although this has never been formally tested in a
Rapid warming of venous tissue minimised cell injuryrandomised trial. This resistance may lie in the pre-
even in the absence of cryoprotectant and regardlessservation of viable cells within the graft. Sepsis re-
of cooling rate. If, however, tissue frozen withoutsistance would clearly be a major advantage in patients
DMSO was warmed slowly, a substantial increase inrequiring synthetic haemodialysis access or bypass
cell damage was observed: conversely, warming rategrafting through infected fields, where graft infection
had little influence on cell damage in samples frozenis the major cause of failure.
in 10% DMSO. Simple washing of tissue to removeThis study shows that it is possible to preserve
cryoprotectant did not increase cell injury.human venous tissue using simple cryopreservation
techniques. These techniques cause some damage to
smooth-muscle cells, but leave the majority of cells
intact. There was no evidence of an influence of cooling Acknowledgements
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terms of smooth-muscle cell damage; but this method
may not be applicable to whole-vein grafts. Fast warm-
ing of frozen whole-arterial grafts and heart valves
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